Targeting CD56 with an antibody-drug conjugate in Merkel cell carcinoma

被引：2
|
作者：
Leiendecker, L. [1 ,2 ,3 ]
Jung, P. S. [1 ,2 ,3 ,4 ]
Obenauf, A. C. [1 ]
机构：
[1] Vienna BioCtr VBC, Res Inst Mol Pathol IMP, Campus Vienna BioCtr 1, A-1030 Vienna, Austria
[2] Univ Vienna, Doctoral Sch, Vienna BioCtr PhD Program, A-1030 Vienna, Austria
[3] Med Univ Vienna, A-1030 Vienna, Austria
[4] Med Univ Vienna, Dept Dermatol, Vienna, Austria
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2022年 / 186卷 / 02期
关键词：
D O I：
10.1111/bjd.20894
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：209 / 210
页数：2
相关论文
共 50 条
  • [21] An antibody-drug conjugate for endometrioid carcinoma based on the expression of cell adhesion molecule 1
    Hagiyama, Man
    Yoneshige, Azusa
    Otani, Tomoyuki
    Wada, Akihiro
    Takeuchi, Fuka
    Shoya, Yuji
    Inoue, Takao
    Ito, Akihiko
    MOLECULAR & CELLULAR ONCOLOGY, 2024, 11 (01)
  • [22] Therapeutic Targeting of CD74 with STRO-001 Antibody-Drug Conjugate in AML and ALL
    Le, Quy
    Leonti, Amanda R.
    Tang, Thao T.
    Castro, Sommer
    Nourigat-Mckay, Cynthia
    Perkins, LaKeisha
    Ries, Rhonda E.
    Smith, Jenny L.
    Hylkema, Tiffany A.
    Pardo, Laura
    Abrahams, Cristina
    Bedard, Kristin
    Molina, Arturo
    Brodersen, Lisa Eidenschink
    Loken, Michael R.
    Meshinchi, Soheil
    BLOOD, 2021, 138
  • [23] Immunoregulation by IL-7R-targeting antibody-drug conjugate
    Yang, Shiqi
    Yasunaga, Masahiro
    Anzai, Takahiro
    CANCER SCIENCE, 2023, 114 : 1990 - 1990
  • [24] Preclinical development of a novel antibody-drug conjugate targeting "cold" tumors
    Kaplan, Angelo
    Attanasio, Nickolas
    Do, To Uyen T.
    Swaminathan, Sudha
    Bisht, Arnima
    Lou, San Lin
    Allen, Jason
    Boyd, Robert
    Ackroyd, James E.
    Feldman, Gleb
    Rohlff, Christian
    Dusek, Rachel L.
    CANCER RESEARCH, 2018, 78 (13)
  • [25] Antibody-drug conjugate targeting tissue factor for pancreatic cancer treatment
    Tsumura, Ryo
    Anzai, Takahiro
    Manabe, Shino
    Takashima, Hiroki
    Koga, Yoshikatsu
    Yasunaga, Masahiro
    Matsumura, Yasuhiro
    CANCER SCIENCE, 2021, 112 : 725 - 725
  • [26] A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies
    Kim, S. Y.
    Theunissen, J-W
    Balibalos, J.
    Liao-Chan, S.
    Babcock, M. C.
    Wong, T.
    Cairns, B.
    Gonzalez, D.
    van der Horst, E. H.
    Perez, M.
    Levashova, Z.
    Chinn, L.
    D'Alessio, J. A.
    Flory, M.
    Bermudez, A.
    Jackson, D. Y.
    Ha, E.
    Monteon, J.
    Bruhns, M. F.
    Chen, G.
    Migone, T-S
    BLOOD CANCER JOURNAL, 2015, 5 : e316 - e316
  • [27] Targeting a Radiosensitizing Antibody-Drug Conjugate to a Radiation-Inducible Antigen
    Lewis, Calvin D.
    Singh, Abhay K.
    Hsu, Fong-Fu
    Thotala, Dinesh
    Hallahan, Dennis E.
    Kapoor, Vaishali
    CLINICAL CANCER RESEARCH, 2021, 27 (11) : 3224 - 3233
  • [28] TARGETING CD70 IN NON-HODGKIN LYMPHOMA AND RENAL CELL CARCINOMA: A PHASE 1 STUDY OF THE ANTIBODY-DRUG CONJUGATE SGN-75
    Ansell, S. M.
    Thompson, J. A.
    Infante, J.
    Heath, E. I.
    Whiting, N. C.
    Zhao, B.
    Forero-Torres, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 174 - 174
  • [29] Targeting BCMA in Multiple Myeloma: Advances in Antibody-Drug Conjugate Therapy
    Xing, Lijie
    Liu, Yuntong
    Liu, Jiye
    CANCERS, 2023, 15 (08)
  • [30] Immunoregulation by IL-7R-targeting antibody-drug conjugate
    Yang, Shiqi
    Yasunaga, Masahiro
    Anzai, Takahiro
    CANCER SCIENCE, 2024, 115 : 619 - 619
12345